An Open-Label, Single-Arm, Phase 1 Study to Assess Biomarker Effects, Efficacy, and Safety of Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia

ανά Patton, William Nigel, Lindeman, Robert, Butler, Andrew C., Kipps, Thomas J., Jewell, Roxanne C., Laubscher, Kevin H., Zhou, YanYan, Lewis, Eric, Sedoti, Donna, Witman, Philip, Fang, Lei, Chan, Geoffrey
Τόπος έκδοσης Leuk Lymphoma (2015)

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

ανά Choueiri, Toni K., Vaishampayan, Ulka, Rosenberg, Jonathan E., Logan, Theodore F., Harzstark, Andrea L., Bukowski, Ronald M., Rini, Brian I., Srinivas, Sandy, Stein, Mark N., Adams, Laurel M., Ottesen, Lone H., Laubscher, Kevin H., Sherman, Laurie, McDermott, David F., Haas, Naomi B., Flaherty, Keith T., Ross, Robert, Eisenberg, Peter, Meltzer, Paul S., Merino, Maria J., Bottaro, Donald P., Linehan, W. Marston, Srinivasan, Ramaprasad
Έκδοση 2013